1,217 Shares in Becton, Dickinson and Company (NYSE:BDX) Acquired by Brown Advisory Securities LLC

Brown Advisory Securities LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX) during the first quarter, according to its most recent filing with the SEC. The institutional investor purchased 1,217 shares of the medical instruments supplier’s stock, valued at approximately $223,000.

A number of other large investors have also made changes to their positions in BDX. BlackRock Inc. raised its stake in shares of Becton, Dickinson and by 2,427.8% in the first quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock valued at $3,034,470,000 after buying an additional 15,887,611 shares during the period. Vanguard Group Inc. raised its stake in Becton, Dickinson and by 5.3% in the first quarter. Vanguard Group Inc. now owns 15,902,168 shares of the medical instruments supplier’s stock valued at $2,917,094,000 after buying an additional 796,034 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Becton, Dickinson and by 6.5% in the first quarter. JPMorgan Chase & Co. now owns 3,967,843 shares of the medical instruments supplier’s stock valued at $727,863,000 after buying an additional 242,081 shares during the last quarter. Wells Fargo & Company MN raised its stake in Becton, Dickinson and by 1.2% in the first quarter. Wells Fargo & Company MN now owns 3,283,068 shares of the medical instruments supplier’s stock valued at $602,246,000 after buying an additional 39,362 shares during the last quarter. Finally, Fundsmith LLP raised its stake in shares of Becton, Dickinson and by 3.2% in the first quarter. Fundsmith LLP now owns 2,296,613 shares of the medical instruments supplier’s stock worth $421,291,000 after buying an additional 71,691 shares in the last quarter. 75.57% of the stock is currently owned by hedge funds and other institutional investors.

Becton, Dickinson and Company (BDX) traded down 0.76% during trading on Friday, hitting $197.79. 350,215 shares of the company traded hands. The firm has a market capitalization of $45.01 billion, a P/E ratio of 57.28 and a beta of 1.05. Becton, Dickinson and Company has a 12-month low of $161.29 and a 12-month high of $206.63. The stock has a 50-day moving average price of $199.60 and a 200-day moving average price of $188.53.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.44 by $0.02. The firm had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The business’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.35 EPS. Equities analysts expect that Becton, Dickinson and Company will post $9.46 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be paid a $0.73 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a yield of 1.47%. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 83.43%.

COPYRIGHT VIOLATION WARNING: “1,217 Shares in Becton, Dickinson and Company (NYSE:BDX) Acquired by Brown Advisory Securities LLC” was reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.com-unik.info/2017/08/18/brown-advisory-securities-llc-invests-223000-in-becton-dickinson-and-company-nysebdx-updated.html.

A number of research analysts have issued reports on BDX shares. Evercore ISI upgraded shares of Becton, Dickinson and from an “in-line” rating to an “outperform” rating and upped their target price for the company from $186.00 to $200.00 in a research report on Monday, April 24th. Zacks Investment Research downgraded shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Thursday, May 4th. Raymond James Financial, Inc. raised shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and decreased their price target for the stock from $210.00 to $180.00 in a research note on Friday, June 30th. Cowen and Company reaffirmed an “outperform” rating and set a $230.00 price target (up from $200.00) on shares of Becton, Dickinson and in a research note on Monday, July 10th. Finally, BidaskClub raised shares of Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $195.79.

In other Becton, Dickinson and news, EVP Ribo Alberto Mas sold 7,463 shares of the company’s stock in a transaction on Monday, August 14th. The stock was sold at an average price of $201.41, for a total value of $1,503,122.83. Following the completion of the transaction, the executive vice president now owns 29,323 shares in the company, valued at approximately $5,905,945.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nabil Shabshab sold 6,149 shares of the company’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $201.76, for a total value of $1,240,622.24. Following the completion of the transaction, the insider now owns 15,648 shares of the company’s stock, valued at approximately $3,157,140.48. The disclosure for this sale can be found here. Insiders sold a total of 57,631 shares of company stock valued at $11,112,178 in the last 90 days. Corporate insiders own 1.40% of the company’s stock.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

What are top analysts saying about Becton Dickinson and Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Becton Dickinson and Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit